₹-14.45
(Market cap
₹37,294 Cr
Recently Viewed
Clear AllMarket cap
₹37,294 Cr
Revenue (TTM)
₹4,461 Cr
P/E Ratio
114.1
P/B Ratio
8.1
Div. Yield
17.1 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹327 Cr
ROE
9.3 %
ROCE
11.5 %
Industry P/E
49.48
EV/EBITDA
37.4
Debt to Equity
0.2
Book Value
₹88.8
EPS
₹7.1
Face value
10
Shares outstanding
518,121,029
CFO
₹8,224.97 Cr
EBITDA
₹8,074.19 Cr
Net Profit
₹2,549.24 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aster Dm Health
| 14.3 | 5.6 | 27.3 | 39.6 | 42.1 | 36.4 | -- |
|
BSE Healthcare
| 2.7 | 5.2 | 8.2 | 6.5 | 25.0 | 13.8 | 11.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Aster Dm Health
| 18.5 | 27.2 | 77.3 | 33.0 | 3.9 | 1.9 | -0.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aster Dm Health
|
705.4 | 37,294.4 | 4,461.2 | 397.5 | 13.4 | 9.1 | 114.1 | 8.1 |
| 242.4 | 3,879.3 | 1,041.9 | 96.4 | 12.0 | 11.5 | 40.2 | 3.3 | |
| 442.2 | 14,025.4 | 1,976.2 | 160.7 | 14.1 | 6.7 | 111.3 | 7.1 | |
| 4,972.9 | 2,405.9 | 450.7 | 69.9 | 22.1 | 26.7 | 34.4 | 7.2 | |
| 577.6 | 8,618.5 | 2,478.2 | 24.7 | 8.4 | 4.2 | 454.8 | 6.4 | |
| 406.0 | 3,798.9 | 1,451.5 | 182.9 | 15.5 | 29.2 | 20.8 | 5.4 | |
| 1,245.0 | 8,319.3 | 1,433.4 | 188.7 | 17.4 | 13.8 | 44.1 | 5.6 | |
| 5,767.2 | 6,539.9 | 1,529.9 | 235.8 | 21.2 | 20.7 | 27.7 | 5.2 | |
| 1,236.4 | 12,745.7 | 1,613.3 | 259.9 | 23.0 | 17.3 | 49.5 | 8.0 | |
| 766.1 | 7,226.6 | 1,089.4 | 165.1 | 17.4 | 10.2 | 43.2 | 4.2 |
Aster DM Healthcare Limited provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail... Pharmacies, and Others segments. The company operates hospitals and in-house pharmacies at the hospitals; and clinics and in-house pharmacies at the clinics, as well as retail pharmacies and optical outlets. It also offers healthcare consultancy and other services. The company was founded in 1987 and is headquartered in Dubai, United Arab Emirates. Read more
Incorporated
2008
Chairman
Azad Moopen
Managing Director
Azad Moopen
Headquarters
Bengaluru, Karnataka
Website
Looking for more details about Aster DM Healthcare Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Aster DM Healthcare Ltd is ₹705.35 (NSE) and ₹706.70 (BSE) as of 28-Apr-2026 13:39 IST. Aster DM Healthcare Ltd has given a return of 42.09% in the last 3 years.
The P/E ratio of Aster DM Healthcare Ltd is 114.05 times as on 27-Apr-2026, a 130 premium to its peers’ median range of 49.48 times.
The P/B ratio of Aster DM Healthcare Ltd is 8.11 times as on 27-Apr-2026, a 12 premium to its peers’ median range of 7.25 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
4.50
|
7.95
|
|
2024
|
158.09
|
4.89
|
|
2023
|
28.39
|
2.97
|
|
2022
|
18.69
|
2.49
|
|
2021
|
46.19
|
2.02
|
The 52-week high and low of Aster DM Healthcare Ltd are Rs 732.20 and Rs 496.95 as of 28-Apr-2026.
Aster DM Healthcare Ltd has a market capitalisation of ₹ 37,294 Cr as on 27-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Aster DM Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.